Hugh Smyth

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	8843	4966
h-endeksi	52	35
i10-endeksi	145	110

1100

550

275

825

20052006200720082009201020112012201320142015201620172018201920202021202220232024202541 53 49 56 49 100 163 228 272 295 384 371 406 601 722 737 1011 1062 983 991 178

Genel erişim

Tümünü görüntüle

40 makale

15 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Ashlee BrunaughAssistant Professor, Department of Pharmaceutical Sciences, University of Michiganmed.umich.edu üzerinde doğrulanmış e-posta adresine sahip
Robert O. Williams IIIUniversity of Texas at Austinaustin.utexas.edu üzerinde doğrulanmış e-posta adresine sahip
Ibrahim M. El-SherbinyFounding Chairman, Nanoscience Prog, Director, Center for Mat. Sci, Zewail City of Sci & Technologyzewailcity.edu.eg üzerinde doğrulanmış e-posta adresine sahip
Marek OsinskiDistinguished Professor, University of New Mexicochtm.unm.edu üzerinde doğrulanmış e-posta adresine sahip
Tania F. Bahamondez-CanasAssociate Professor, Universidad de Valparaisouv.cl üzerinde doğrulanmış e-posta adresine sahip
Zachary WarnkenUniversity of Texas College of Pharmacyutexas.edu üzerinde doğrulanmış e-posta adresine sahip
Silvia Ferratiaegleabio.com üzerinde doğrulanmış e-posta adresine sahip
Zhen XuUS Food and Drug Administrationfda.hhs.gov üzerinde doğrulanmış e-posta adresine sahip
Jasmim LealThe University of Texas at Austinutexas.edu üzerinde doğrulanmış e-posta adresine sahip
Daniel F Moraga-EspinozaThe University of Texas at Austin; Universidad de Valparaísoutexas.edu üzerinde doğrulanmış e-posta adresine sahip
Leisha Armijo MartinTexas A&M University-Corpus Christitamucc.edu üzerinde doğrulanmış e-posta adresine sahip
Nihal BandaraSenior Lecturer in Oral Microbiology, University of Bristolbristol.ac.uk üzerinde doğrulanmış e-posta adresine sahip
imran saleemProfessor in nanomedicine, Liverpool John Moores Universityljmu.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Yekaterina BrandtPost Doctoral Fellow, UNMsalud.unm.edu üzerinde doğrulanmış e-posta adresine sahip
Hairui ZhangUltragenyx Pharmaceutical Inc.utexas.edu üzerinde doğrulanmış e-posta adresine sahip
Dea Herrera-RuizPITC, Facultad de Farmacia, UAEMuaem.mx üzerinde doğrulanmış e-posta adresine sahip
Dale L. HuberDistinguished Member of the Technical Staff, Sandia National Labssandia.gov üzerinde doğrulanmış e-posta adresine sahip
Gennady SmolyakovResearch Associate Professor, Dept. of Electrical & Computer Engineering, University of New Mexicochtm.unm.edu üzerinde doğrulanmış e-posta adresine sahip
Nathan WithersPost-doc University of New Mexicounm.edu üzerinde doğrulanmış e-posta adresine sahip
Li DingAmgen Inc.amgen.com üzerinde doğrulanmış e-posta adresine sahip

Takip et

Hugh Smyth

Professor, Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas

mail.utexas.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Pharmaceutics infectious disease mucosal drug delivery formulation


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
3D Printing technologies for drug delivery: a review LK Prasad, H Smyth Drug development and industrial pharmacy 42 (7), 1019-1031, 2016	551	2016
Physicochemical properties of mucus and their impact on transmucosal drug delivery J Leal, HDC Smyth, D Ghosh International journal of pharmaceutics 532 (1), 555-572, 2017	514	2017
The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers HDC Smyth Advanced drug delivery reviews 55 (7), 807-828, 2003	230	2003
Excipient development for pharmaceutical, biotechnology, and drug delivery systems A Katdare, M Chaubal CRC Press, 2006	198	2006
Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics AJ Hickey, HM Mansour, MJ Telko, Z Xu, HDC Smyth, T Mulder, ... Journal of pharmaceutical sciences 96 (5), 1282-1301, 2007	197	2007
Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms LM Armijo, SJ Wawrzyniec, M Kopciuch, YI Brandt, AC Rivera, NJ Withers, ... Journal of Nanobiotechnology 18, 1-27, 2020	165	2020
Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes JO Morales, KR Fathe, A Brunaugh, S Ferrati, S Li, M Montenegro-Nicolini, ... The AAPS journal 19, 652-668, 2017	153	2017
Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles IM El-Sherbiny, HDC Smyth Molecular pharmaceutics 9 (2), 269-280, 2012	152	2012
Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations MJ Donovan, HDC Smyth International journal of pharmaceutics 402 (1-2), 1-9, 2010	152	2010
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9 JS LaFountaine, K Fathe, HDC Smyth International journal of pharmaceutics 494 (1), 180-194, 2015	150	2015
Dry powder inhaler device influence on carrier particle performance MJ Donovan, SH Kim, V Raman, HD Smyth Journal of pharmaceutical sciences 101 (3), 1097-1107, 2012	147	2012
Carriers in drug powder delivery: implications for inhalation system design HDC Smyth, AJ Hickey American journal of drug delivery 3, 117-132, 2005	127	2005
Formulation and device design to increase nose to brain drug delivery ZN Warnken, HDC Smyth, AB Watts, S Weitman, JG Kuhn, RO Williams III Journal of Drug Delivery Science and Technology 35, 213-222, 2016	118	2016
Controlled pulmonary drug delivery HDC Smyth, AJ Hickey Springer Science & Business Media, 2011	117	2011
Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments H Zhang, J Leal, MR Soto, HDC Smyth, D Ghosh Pharmaceutics 12 (11), 1042, 2020	115	2020
Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery:(I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres IM El-Sherbiny, HDC Smyth International journal of pharmaceutics 395 (1-2), 132-141, 2010	114	2010
Swellable microparticles as carriers for sustained pulmonary drug delivery IM El‐Sherbiny, S McGill, HDC Smyth Journal of pharmaceutical sciences 99 (5), 2343-2356, 2010	113	2010
Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin IM El-Sherbiny, M Abdel-Mogib, AAM Dawidar, A Elsayed, HDC Smyth Carbohydrate polymers 83 (3), 1345-1354, 2011	108	2011
Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics AJ Hickey, HM Mansour, MJ Telko, Z Xu, HDC Smyth, T Mulder, ... Journal of pharmaceutical sciences 96 (5), 1302-1319, 2007	108	2007
Disruption of the mucus barrier by topically applied exogenous particles SL McGill, HDC Smyth Molecular pharmaceutics 7 (6), 2280-2288, 2010	106	2010

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar